Skip to main content

Glycopyrrolate

NDC 76045-023 · Fresenius Kabi USA, LLC

Generic nameGlycopyrrolate
Dosage formINJECTION
RouteINTRAMUSCULAR, INTRAVENOUS
Active ingredient(s)GLYCOPYRROLATE
Strength.2 mg/mL
Pharmacologic classAnticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
Marketing categoryNDA

Packages

76045-023-30 — 10 SYRINGE in 1 CARTON (76045-023-30) / 3 mL in 1 SYRINGE (76045-023-00)

Billed under HCPCS

J1598 — Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg Medicare Part B payment limit (ASP + 6%): $1.34

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

72162-2598 — GLYCOPYRROLATE, 72205-070 — GLYCOPYRROLATE, 72572-225 — Glycopyrrolate, 72572-226 — Glycopyrrolate, 72603-240 — Glycopyrrolate, 72887-160 — GLYCOPYRROLATE, 75834-193 — glycopyrrolate, 75834-194 — glycopyrrolate, 75834-195 — glycopyrrolate, 75834-196 — glycopyrrolate, 76045-203 — Glycopyrrolate, 76045-206 — Glycopyrrolate, 76045-208 — Glycopyrrolate, 76045-223 — Glycopyrrolate, 79739-7097 — Glycopyrrolate, 80056-160 — Glycopyrrolate, 82983-428 — Glycopyrrolate, 84549-203 — Glycopyrrolate, 84549-204 — Glycopyrrolate, 84549-205 — Glycopyrrolate, +177 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.